Literature DB >> 2288388

Abnormal urinary excretion of polyamines in HHH syndrome (hyperornithinemia associated with hyperammonemia and homocitrullinuria).

H Shimizu1, K Maekawa, Y Eto.   

Abstract

The HHH syndrome (hyperornithinemia associated with hyperammonemia and homocitrullinuria) is characterized by a very rare genetic defect of ornithine transport in mitochondrial membrane. We first demonstrated that a patient with HHH syndrome excreted about 6 times higher amount of polyamines in urine than the control when supplemented with high protein diets and ornithine loading. Each urinary polyamine fraction measured by HPLC method in HHH syndrome appears to be increased, as compared with those of the control. These data suggest that increased urinary excretion of polyamines in this syndrome is closely related to overflowing of plasma polyamine due to an ornithine transport defect in the mitochondrial membrane.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2288388     DOI: 10.1016/s0387-7604(12)80222-1

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  4 in total

1.  Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF Melanoma.

Authors:  Banu Eskiocak; Elizabeth A McMillan; Saurabh Mendiratta; Rahul K Kollipara; Hailei Zhang; Caroline G Humphries; Changguang Wang; Jose Garcia-Rodriguez; Ming Ding; Aubhishek Zaman; Tracy I Rosales; Ugur Eskiocak; Michael P Smith; Jessica Sudderth; Kakajan Komurov; Ralph J Deberardinis; Claudia Wellbrock; Michael A Davies; Jennifer A Wargo; Yonghao Yu; Jef K De Brabander; Noelle S Williams; Lynda Chin; Helen Rizos; Georgina V Long; Ralf Kittler; Michael A White
Journal:  Cancer Discov       Date:  2017-04-28       Impact factor: 39.397

2.  Insights into the mutation-induced HHH syndrome from modeling human mitochondrial ornithine transporter-1.

Authors:  Jing-Fang Wang; Kuo-Chen Chou
Journal:  PLoS One       Date:  2012-01-26       Impact factor: 3.240

Review 3.  The hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.

Authors:  Diego Martinelli; Daria Diodato; Emanuela Ponzi; Magnus Monné; Sara Boenzi; Enrico Bertini; Giuseppe Fiermonte; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2015-03-11       Impact factor: 4.123

4.  Reversible Leukoencephalopathy in a Man with Childhood-onset Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome.

Authors:  Yumi Hoshino; Minori Kodaira; Atsuhiro Matsuno; Tomoki Kaneko; Tetsuhiro Fukuyama; Kyoko Takano; Masahide Yazaki; Yoshiki Sekijima
Journal:  Intern Med       Date:  2021-08-24       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.